1
|
Bielack SS, Kempf-Bielack B, Heise U,
Schwenzer D and Winkler K: Combined modality treatment for
osteosarcoma occurring as a second malignant disease. Cooperative
German Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol.
17:1164. 1999.
|
2
|
Bielack SS, Kempf-Bielack B, Delling G, et
al: Prognostic factors in high-grade osteosarcoma of the
extremities or trunk: an analysis of 1,702 patients treated on
neoadjuvant cooperative osteosarcoma study group protocols. J Clin
Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chou AJ, Geller DS and Gorlick R: Therapy
for osteosarcoma: where do we go from here? Pediatric Drugs.
10:315–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kager L, Zoubek A, Pötschger U, et al:
Cooperative German-Austrian-Swiss Osteosarcoma Study Group: Primary
metastatic osteosarcoma: presentation and outcome of patients
treated on neoadjuvant Cooperative Osteosarcoma Study Group
protocols. J Clin Oncol. 21:2011–2018. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Meyer WH, Pratt CB, Poquette CA, et al:
Carboplatin/ifosfamide window therapy for osteosarcoma: results of
the St Jude Children’s Research Hospital OS-91 trial. J Clin Oncol.
19:171–182. 2001.PubMed/NCBI
|
7
|
Ferguson WS, Harris MB, Goorin AM, et al:
Presurgical window of carboplatin and surgery and multidrug
chemotherapy for the treatment of newly diagnosed metastatic or
unresectable osteosarcoma: pediatric oncology group trial. J
Pediatr Hematol Oncol. 23:340–348. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Link MP, Goorin AM, Miser AW, et al: The
effect of adjuvant chemotherapy on relapse-free survival in
patients with osteosarcoma of the extremity. N Engl J Med.
314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hegde P, Qi R, Abernathy K, et al: A
concise guide to cDNA microarray analysis. Biotechniques.
29:548–550. 2000.PubMed/NCBI
|
10
|
DeRisi J, Penland L, Brown PO, et al: Use
of a cDNA microarray to analyse gene expression patterns in human
cancer. Nat Genet. 14:457–460. 1996. View Article : Google Scholar : PubMed/NCBI
|
11
|
Perou CM, Jeffrey SS, Van De Rijn M, et
al: Distinctive gene expression patterns in human mammary
epithelial cells and breast cancers. Proc Nat Acad Sci USA.
96:9212–9217. 1999. View Article : Google Scholar : PubMed/NCBI
|
12
|
Trougakos IP, Chondrogianni N, Amarantos
I, et al: Genome-wide transcriptome profile of the human
osteosarcoma SA OS and U-2 OS cell lines. Cancer Genet Cytogenet.
196:109–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Luo Y, Deng Z and Chen J: Pivotal
regulatory network and genes in osteosarcoma. 9:569–575. 2013.
|
14
|
Wolf M, El-Rifai We, Tarkkanen M, et al:
Novel findings in gene expression detected in human osteosarcoma by
cDNA microarray. Cancer genetics and cytogenetics. 123:128–132.
2000. View Article : Google Scholar
|
15
|
Kubista B, Klinglmueller F, Bilban M, et
al: Microarray analysis identifies distinct gene expression
profiles associated with histological subtype in human
osteosarcoma. Int Orthop. 35:401–411. 2011. View Article : Google Scholar :
|
16
|
Squire JA, Pei J, Marrano P, et al:
High-resolution mapping of amplifications and deletions in
pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
Genes, Chromosomes Cancer. 38:215–225. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Endo-Munoz L, Cumming A, Rickwood D, et
al: Loss of osteoclasts contributes to development of osteosarcoma
pulmonary metastases. Cancer Res. 70:7063–7072. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bolstad BM; preprocessCore. A collection
of pre-processing functions. R package version:1.0. 2013
|
19
|
Bolstad BM, Irizarry RA, Astrand M and
Spreed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kennedy CL, Najdovska M, Tye H, et al:
Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric
tumourigenesis. Oncogene. 2013.PubMed/NCBI
|
21
|
Zhang S and Cao J: A close examination of
double filtering with fold change and T test in microarray
analysis. BMC Bioinformatics. 10:4022009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Smyth GK; Limma. Linear models for
microarray data. Bioinformatics and Computational Biology Solutions
Using R and Bioconductor. 5. Springer; New York, NY: pp. 397–420.
2005, View Article : Google Scholar
|
23
|
Ashburner M, Ball CA, Blake JA, et al:
Gene ontology: tool for the unification of biology. the gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kanehisa M and Goto S: KEGG: kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
25
|
Usadel B, Obayashi T, Mutwil M, et al:
Co-expression tools for plant biology: opportunities for hypothesis
generation and caveats. Plant Cell & Environ. 32:1633–1651.
2009. View Article : Google Scholar
|
26
|
Barretina J, Caponigro G, Stransky N, et
al: The cancer cell line encyclopedia enables predictive modelling
of anticancer drug sensitivity. Nature. 483:603–607. 2012.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Keshava Prasad TS, Goel R, Kandasamy K, et
al: Human protein reference database-2009 update. Nucleic Acids
Res. 37:D767–D772. 2009. View Article : Google Scholar
|
28
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
29
|
Bidkhori G, Narimani Z, Ashtiani SH,
Moeini A, Nowzari-Dalini A and Masoudi-Nejad A: Reconstruction of
an integrated genome-scale co-expression network reveals key
modules involved in lung adenocarcinoma. PLoS One. 8:e675522013.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Ruggero D and Pandolfi PP: Does the
ribosome translate cancer? Nat Rev Cancer. 3:179–192. 2003.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Dickson BJ: Molecular mechanisms of axon
guidance. Science. 298:1959–1964. 2002. View Article : Google Scholar : PubMed/NCBI
|
32
|
Ilyin SE, González-Gómez I, Romanovicht A,
Gayle D, Gilles FH and Plata-Salamán CR: Autoregulation of the
interleukin-1 system and cytokine-cytokine interactions in primary
human astrocytoma cells. Brain Res Bull. 51:29–34. 2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Luo M and Guan JL: Focal adhesion kinase:
A prominent determinant in breast cancer initiation, progression
and metastasis. Cancer Lett. 289:127–139. 2010. View Article : Google Scholar :
|
34
|
Housa D, Housova J, Vernerova Z and
Haluzik M: Adipocytokines and cancer. Physiol Res. 55:2332006.
|
35
|
Lehmann BD, Bauer JA, Chen X, et al:
Identification of human triple-negative breast cancer subtypes and
preclinical models for selection of targeted therapies. J Clin
Invest. 121:2750–2767. 2011. View
Article : Google Scholar : PubMed/NCBI
|
36
|
Guo CJ, Pan Q, Cheng T, Jiang B, Chen GY
and Li DG: Changes in microRNAs associated with hepatic stellate
cell activation status identify signaling pathways. FEBS Journal.
276:5163–5176. 2009. View Article : Google Scholar : PubMed/NCBI
|
37
|
Poola I, DeWitty RL, Marshalleck JJ,
Bhatnagar R, Abraham J and Leffall LD: Identification of MMP-1 as a
putative breast cancer predictive marker by global gene expression
analysis. Nat Med. 11:481–483. 2005. View
Article : Google Scholar : PubMed/NCBI
|
38
|
Husmann K, Arlt MJ, Muff R, et al: Matrix
metalloproteinase 1 promotes tumor formation and lung metastasis in
an intratibial injection osteosarcoma mouse model. Biochim Biophys
Acta. 1832:347–354. 2013. View Article : Google Scholar
|
39
|
Uchibori M, Nishida Y, Nagasaka T, Yamada
Y, Nakanishi K and Ishiguro N: Increased expression of
membrane-type matrix metalloproteinase-1 is correlated with poor
prognosis in patients with osteosarcoma. Int J Oncol. 28:33–42.
2006.
|
40
|
Westermarck J and Kähäri VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999.PubMed/NCBI
|
41
|
Chen JK, Taipale J, Young KE, Maiti T and
Beachy PA: Small molecule modulation of smoothened activity. Pro
Nat Acad Sci. 99:14071–14076. 2002. View Article : Google Scholar
|
42
|
Hirotsu M, Setoguchi T, Sasaki H, et al:
Smoothened as a new therapeutic target for human osteosarcoma. Mol
Cancer. 9:52010. View Article : Google Scholar : PubMed/NCBI
|
43
|
Romeo S and Dei Tos AP: Soft tissue tumors
associated with EWSR1 translocation. Virchows Arc. 456:219–234.
2010. View Article : Google Scholar
|
44
|
Debelenko LV, McGregor LM, Shivakumar BR,
Dorfman HD and Raimondi SC: A novel EWSR1-CREB311 fusion transcript
in a case of small cell osteosarcoma. Genes Chromosomes Cancer.
50:1054–1062. 2011. View Article : Google Scholar : PubMed/NCBI
|
45
|
Antonescu CR, Zhang L, Chang NE, et al:
EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A
molecular analysis of sixty-six cases, including soft tissue, bone
and visceral lesions, showing common involvement of the EWSR1 gene.
Genes Chromosomes Cancer. 49:1114–1124. 2010. View Article : Google Scholar : PubMed/NCBI
|
46
|
Vecchione A, Ishii H, Baldassarre G, et
al: FEZ1/LZTS1 is down-regulated in high-grade bladder cancer and
its restoration suppresses tumorigenicity in transitional cell
carcinoma cells. Am J Pathol. 160:1345–1352. 2002. View Article : Google Scholar : PubMed/NCBI
|
47
|
Tovar C, Rosinski J, Filipovic Z, et al:
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in
cancer: implications for therapy. Proc Natl Acad Sci USA.
103:1888–1893. 2006. View Article : Google Scholar : PubMed/NCBI
|
48
|
Guo Z, Tang W, Yuan J, et al: BRSK2 is
activated by cyclic AMP-dependent protein kinase A through
phosphorylation at THR260. Biochem Biophys Res Commun. 347:867–871.
2006. View Article : Google Scholar : PubMed/NCBI
|